Drug that holds back return of ovarian cancer gets UK licence

Niraparib, which can buy months of time before relapse after chemotherapy, is yet to be assessed for free availability on NHS

A pill treatment that holds back ovarian cancer and has the potential to prolong life has been launched in the UK.

Trial results have shown that niraparib, taken once daily, can buy months of time before the disease returns after chemotherapy.